Institutional Only|Drovix does not deal with individual investors and does not accept deposits or provide retail trading services.

Drovix.
Financial insights and market analysis editorial workspace
Education

The True Cost of Institutional Liquidity: Beyond the Quoted Spread

Spread is the headline. The real cost of wholesale liquidity is a stack of seven components — and only one of them shows up on the quote screen. A 2026 breakdown for liquidity buyers.

HomeResourcesInsights & News
25 May 2026Drovix Research Desk9 min

When a broker COO compares two liquidity providers, the first metric on the page is almost always quoted spread on EUR/USD. It is the wrong metric, and it has been the wrong metric for at least a decade — but it persists because it is easy to compute and easy to put in a sales deck.

The actual cost of wholesale liquidity is a stack of seven components. Quoted spread is one of them. The others, properly quantified, can swing the all-in cost of execution by more than the spread itself.

Component 1 — Quoted spread

The simplest piece. Top-of-book bid-ask, time-weighted across your trading sessions. This is the only component that appears on the quote screen, and it accounts for roughly 30–50% of all-in cost for a mid-sized broker.

Component 2 — Effective spread

Effective spread is the difference between the price you actually got and the mid at the moment of order arrival. It can be wider or tighter than the quoted spread depending on aggression, latency, and venue behaviour. Our microstructure survey article goes into the measurement in detail.

Component 3 — Last-look slippage

On any venue that uses last-look, some orders are rejected and re-quoted at a worse price. If the rejection policy is symmetric, this is a wash in expectation. If it is asymmetric — and many venues still are — it costs the consumer 0.3 to 0.8 pips per million on average. This is the single largest hidden cost in 2026, and the one buyers most often fail to measure.

Component 4 — Capacity decay

The second slice of a large order is rarely filled at the same price as the first. The decay curve depends on the depth profile of the venue and the smartness of the smart router. On thin venues, a USD 20m EUR/USD clip can pay 0.8 pips more on the second half than the first.

Component 5 — Per-million commission

The explicit fee, billed by the provider. Usually USD 5–25 per million in FX, more in CFDs. This is transparent and the easiest component to negotiate; treat it as a known constant rather than a focus of optimisation.

Component 6 — Credit cost

If you are running pre-funded margin, the cost is the opportunity cost of the working capital sitting at your provider's bank. If you are running on a credit line, the cost is the all-in line fee plus any covenant burden. For a mid-sized broker this can be a five-to-seven-figure annual line item.

Component 7 — Operational and connectivity cost

FIX engines, drop-copy, reconciliation, monthly platform fees, the headcount required to run the relationship. Often invisible because it is split across infrastructure and ops budgets, but for a small broker it can dominate per-million economics.

Putting it together — the all-in number

Sum all seven components, normalise to pips per million traded, and that is your all-in cost. In a typical 2026 mid-sized FX broker book, the breakdown looks roughly like this:

  • Quoted spread: 0.4 pips
  • Effective vs quoted gap: 0.2 pips
  • Last-look slippage (asymmetric venue): 0.5 pips
  • Capacity decay on large clips: 0.3 pips
  • Commission (USD 8 / m): 0.08 pips
  • Credit cost (annualised): 0.05 pips
  • Ops and connectivity: 0.05 pips
All-in: ~1.6 pips per million — of which the headline `spread' was only a quarter.

How Drovix prices each component

Drovix's commercial model is structured so that components 5 through 7 are explicit line items on every monthly statement. Components 1 through 4 are reported in the monthly execution-quality pack at venue-tag granularity, which means you can see exactly where your money is going.

We default to symmetric last-look venues and route around asymmetric ones automatically. We publish capacity curves per instrument so you can size clips against real depth rather than the top-of-book illusion. None of this is novel — it is what serious institutional plumbing should look like — but it is surprisingly rare in the prime-of-prime layer.

What to do tomorrow morning

Ask your incumbent provider for the seven-component breakdown on your own flow for the last quarter. If they cannot produce it, that is a finding. If they can produce it but it shows a different shape than this article, that is information about your flow. Either way, you will know more than your competitors who are still comparing quoted spreads on a screen.

Analyst Desk

Drovix Research Desk

Institutional Research

Drovix Research Desk publishes institutional-grade analysis covering macro events, cross-asset correlations, and execution insights for professional market participants.

Frequently Asked Questions

Q1.Why is quoted spread a misleading metric?+
Because it ignores fill probability, last-look slippage, capacity decay on larger clips, and the cost of carrying credit. Two providers with identical top-of-book spread can differ by 0.5–1.5 pips on actual all-in execution cost.
Q2.What is the single biggest hidden cost?+
For most retail brokers in 2026, it is asymmetric last-look slippage — fills that are quietly worse than the quoted price because the venue rejected the move-up cases. A symmetric venue eliminates this; an asymmetric one can quietly cost 0.3–0.8 pips per million.
Q3.How do I measure all-in cost myself?+
Reconstruct the executable price at the moment of order arrival from your full depth-of-book recording, then compare it to the actual fill price, including any rejected attempts. Sum across all tickets, divide by notional, and that is your true effective spread.

Related Reads

Education

From RFP to First Fill: A 6-Week Liquidity Onboarding Playbook

Next Read

Education

Switching Liquidity Providers Without Breaking Execution Quality

Next Read

Education

Drovix Liquidity for Regulated Brokers: A 2026 Buyer's Guide

Next Read

Back to Insights
Drovix.

Institutional-grade liquidity, connectivity, and analytics for professional market participants worldwide.

About

  • Why Drovix
  • About Us
  • Regulation
  • Technology
  • Contact
  • Insights
  • Execution Policy

Legal

  • Privacy
  • Terms and Agreements
  • Client Agreement
  • Regulatory Status
  • Risk Disclosure

Policies

  • AML/KYC Policy
  • Cookie Policy
  • Order Execution Policy
  • Complaints Handling
  • Reverse Solicitation
  • Site map

Risk Warning: Trading leveraged products such as Forex and CFDs carries a significant level of risk and may not be appropriate for all market participants. The value of derivative instruments can fluctuate rapidly, and losses may exceed initial margin. Institutional and professional clients should ensure they fully understand the risks associated with leveraged products before engaging in any transactions. Past performance is not indicative of future results. A significant proportion of professional client accounts incur losses when trading leveraged products. Prospective clients should ensure they have sufficient expertise and resources to bear the risks of leveraged trading. You should not commit capital that you cannot afford to lose.

Important — No Investor Compensation: Important: Client funds held with Drovix (MU) Ltd are not protected by any government deposit guarantee or investor compensation scheme. The Financial Services Commission (FSC) of Mauritius does not operate an investor compensation fund.

The information on this website is intended for institutional and professional clients only. It does not constitute investment advice, a solicitation, or a recommendation to enter into any transaction. Drovix does not provide services to retail clients.

Reverse Solicitation Notice: The information and services on this website are not directed at or intended for distribution to residents or nationals of any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Institutional clients access Drovix (MU) Ltd services on their own initiative. It is the responsibility of each prospective institutional client to ensure compliance with the laws and regulations of their jurisdiction of incorporation or domicile.

This information is not intended for entities or persons in countries or jurisdictions under significant sanctions, including but not limited to Afghanistan, Barbados, Belarus, Burkina Faso, Cameroon, Central African Republic, Cuba, Democratic Republic of Congo, Haiti, Iran, Libya, Mali, Mozambique, Myanmar, Nicaragua, North Korea, Russia, Senegal, Sudan, Syria, Tanzania, Venezuela, Yemen, and Zimbabwe.

All information, products, and services offered on the Drovix website are not intended for entities or persons in Australia, Belgium, Canada, France, Japan, Malaysia, Poland, Ukraine, the United Kingdom, or the United States. The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. Drovix services are available exclusively to eligible institutional and professional clients.

© 2026 Drovix (MU) Ltd. All rights reserved.

Drovix (MU) Ltd is authorised and regulated by the Financial Services Commission (FSC) of Mauritius as an Investment Dealer (Full Service Dealer) under licence number GB21026813.

Drovix (MU) Ltd is not authorised by the United Kingdom Financial Conduct Authority and is not registered with the U.S. SEC, CFTC or NFA. Nothing on this website constitutes a financial promotion under section 21 of the UK Financial Services and Markets Act 2000.

The company operates under www.drovix.com and is registered at C/o SALVUS (Mauritius) Ltd, Silver Bank Tower, Ground Floor, 18 Bank Street, Cybercity, Ebene 72201 Mauritius.